Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,278 | 16 | 96.2% |
| Education | $49.95 | 2 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $291.18 | 5 | $0 (2022) |
| GENZYME CORPORATION | $254.03 | 2 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $209.41 | 2 | $0 (2018) |
| AbbVie, Inc. | $145.75 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $124.77 | 1 | $0 (2018) |
| Genentech USA, Inc. | $92.61 | 1 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $91.66 | 1 | $0 (2017) |
| Aqua Pharmaceuticals | $69.20 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $24.21 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $13.20 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $49.95 | 2 | PFIZER INC. ($49.95) |
| 2018 | $409.87 | 7 | Janssen Scientific Affairs, LLC ($209.41) |
| 2017 | $867.99 | 9 | GENZYME CORPORATION ($254.03) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2022 | PFIZER INC. | EUCRISA (Drug) | Education | In-kind items and services | $34.95 | General |
| Category: DERMATOLOGY | ||||||
| 08/15/2022 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: Inflammation & Immunology | ||||||
| 10/25/2018 | Janssen Scientific Affairs, LLC | Tremfya (Drug) | Food and Beverage | In-kind items and services | $112.94 | General |
| Category: Immunology | ||||||
| 07/24/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Immunology | ||||||
| 07/03/2018 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: DERMATOLOGY | ||||||
| 05/03/2018 | Janssen Scientific Affairs, LLC | Tremfya (Drug) | Food and Beverage | In-kind items and services | $96.47 | General |
| Category: Immunology | ||||||
| 04/03/2018 | LEO Pharma Inc. | PICATO (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: DERMATOLOGY | ||||||
| 03/27/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: DERMATOLOGY | ||||||
| 03/23/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $124.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/07/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $115.76 | General |
| Category: DERMATOLOGY | ||||||
| 08/09/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $107.98 | General |
| Category: DERMATOLOGY | ||||||
| 07/19/2017 | GENZYME CORPORATION | ATOPIC DERMATITIS - DISEASE (Drug) | Food and Beverage | In-kind items and services | $133.77 | General |
| 06/21/2017 | Actelion Pharmaceuticals US, Inc. | VALCHLOR MECHLORETHAMINE (Drug) | Food and Beverage | In-kind items and services | $91.66 | General |
| Category: CANCER | ||||||
| 06/01/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $123.55 | General |
| Category: Immunology | ||||||
| 05/11/2017 | GENZYME CORPORATION | ATOPIC DERMATITIS - DISEASE (Drug) | Food and Beverage | In-kind items and services | $120.26 | General |
| 02/01/2017 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE, SIMPONI | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Immunology | ||||||
| 01/18/2017 | Aqua Pharmaceuticals | Altabax (Drug) | Food and Beverage | Cash or cash equivalent | $69.20 | General |
| Category: Dermatology | ||||||
| 01/12/2017 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $92.61 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 911 | 1,242 | $516,725 | $78,812 |
| 2022 | 14 | 894 | 1,252 | $533,731 | $84,357 |
| 2021 | 15 | 872 | 1,147 | $429,759 | $88,842 |
| 2020 | 13 | 709 | 939 | $373,543 | $64,389 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 223 | 358 | $176,852 | $27,246 | 15.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 199 | 241 | $75,433 | $10,791 | 14.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 113 | 124 | $67,456 | $10,668 | 15.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 62 | 62 | $38,564 | $5,666 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 52 | $35,828 | $5,466 | 15.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 78 | 98 | $33,908 | $5,349 | 15.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 36 | 46 | $29,486 | $4,773 | 16.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 71 | 71 | $28,613 | $3,964 | 13.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $9,912 | $1,568 | 15.8% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 12 | 25 | $9,925 | $1,537 | 15.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 17 | $4,216 | $758.35 | 18.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 11 | 12 | $3,516 | $583.20 | 16.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 32 | 71 | $2,698 | $398.28 | 14.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 53 | $318.00 | $43.71 | 13.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 257 | 409 | $202,046 | $30,881 | 15.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 160 | 200 | $62,600 | $10,192 | 16.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 87 | 96 | $52,224 | $8,988 | 17.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 69 | 69 | $42,646 | $6,682 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 58 | $39,962 | $6,519 | 16.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 64 | 83 | $28,718 | $4,976 | 17.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 82 | 82 | $33,046 | $4,824 | 14.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 33 | 39 | $24,999 | $3,719 | 14.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 19 | 22 | $18,172 | $2,794 | 15.4% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2022 | 11 | 11 | $11,088 | $1,875 | 16.9% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2022 | 14 | 26 | $10,322 | $1,617 | 15.7% |
About Dr. Lawrence Lieblich, MD
Dr. Lawrence Lieblich, MD is a Dermatology healthcare provider based in Smithtown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619985462.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Lieblich, MD has received a total of $1,328 in payments from pharmaceutical and medical device companies, with $49.95 received in 2022. These payments were reported across 18 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,278).
As a Medicare-enrolled provider, Lieblich has provided services to 3,386 Medicare beneficiaries, totaling 4,580 services with total Medicare billing of $316,399. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Smithtown, NY
- Active Since 08/04/2006
- Last Updated 12/08/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1619985462
Products in Payments
- EUCRISA (Drug) $276.18
- ATOPIC DERMATITIS - DISEASE (Drug) $254.03
- Tremfya (Drug) $209.41
- Humira (Biological) $145.75
- DUPIXENT DUPILUMAB INJECTION (Biological) $124.77
- Xolair (Biological) $92.61
- VALCHLOR MECHLORETHAMINE (Drug) $91.66
- Altabax (Drug) $69.20
- COSENTYX (Biological) $24.21
- CIBINQO (Drug) $15.00
- STELARA (Biological) $13.20
- PICATO (Drug) $11.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Smithtown
Dr. Daniel Siegel, M.d, M.D
Dermatology — Payments: $657,817
Michael Fastenberg, M.d, M.D
Dermatology — Payments: $392,151
Ms. Tamara Koss, Md, MD
Dermatology — Payments: $26,724
Dr. Donna Serure, D.o, D.O
Dermatology — Payments: $11,622
Dr. Audra Malerba, D.o, D.O
Dermatology — Payments: $10,668
Barry Solomon, Md, Jd, Faad, MD, JD, FAAD
Dermatology — Payments: $3,753